Journals / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 3

Role of red cell dstribution width in colorectal cancer diagnosis and prognosis

Pages
875–881
Publication Date
2022-05-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found that RDW values were significantly higher in females compared to males (p=0.033), in patients with T3 or T4 tumors compared to those with T1 or T2 tumors (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to assess whether red cell distribution width (RDW) was associated with pre-operative clinical features or post-operative clinicopathological outcomes in patients with colorectal cancer (CRC), and to determine the utility of RDW as a diagnostic or prognostic marker of CRC.
📊
Key Findings & Data:Material and Method: This retrospective cohort study was conducted between January 2018 and May 2021 at a university hospital in Turkey.
💡
Conclusion & Impact:We found that RDW values were significantly higher in females compared to males (p=0.033), in patients with T3 or T4 tumors compared to those with T1 or T2 tumors (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Colorectal cancer · RDW · prognosis

Abstract

Objective: We aimed to assess whether red cell distribution width (RDW) was associated with pre-operative clinical features or post-operative clinicopathological outcomes in patients with colorectal cancer (CRC), and to determine the utility of RDW as a diagnostic or prognostic marker of CRC. Material and Method: This retrospective cohort study was conducted between January 2018 and May 2021 at a university hospital in Turkey. A total of 188 patients histologically diagnosed with CRC who had undergone surgery were included in the study. Results: Our study included 118 (62.77%) male patients, and the mean age of the patients was 66.28±11.71 years. We found that RDW values were significantly higher in females compared to males (p=0.033), in patients with T3 or T4 tumors compared to those with T1 or T2 tumors (p

🔖

Cite This Article

KARAYİĞİT, A., ÖZDEMİR, D. B., DİZEN, H., ÜNAL, B., OZER, İ., ULAŞ, M. (2022). Role of red cell dstribution width in colorectal cancer diagnosis and prognosis. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 3, 875–881. https://ajindex.com/articles/776561

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Pedrazzani C, Tripepi M, Turri G, et al. Prognostic value of red cell distribution width (RDW) in colorectal cancer. Results from a single-center cohort on 591 patients. Sci Rep 2020; 10: 1072. Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging 2016; 11: 967-76.
  2. Song Y, Huang Z, Kang Y, et al. Clinical Usefulness and prognostic value of red cell distribution width in colorectal cancer. Biomed Res Int 2018; 2018: 9858943. Shi C, Xie M, Li L, Li K, Hu BL. The association and diagnostic value of red blood cell distribution width in colorectal cancer. Medicine (Baltimore) 2019; 98: e15560. Jandial A, Kumar S, Bhalla A, Sharma N, Varma N, Varma S. Elevated red cell distribution width as a prognostic marker in severe sepsis: a prospective observational study. Indian J Crit Care Med 2017; 21: 552-62.
  3. Ay S, Eryilmaz MA, Aksoy N, Okus A, Unlu Y, Sevinc B. Is early detection of colon cancer possible with red blood cell distribution width? Asian Pac J Cancer Prev 2015; 16: 753-6.
  4. Kust D, Lucijanic M, Urch K, et al. Clinical and prognostic significance of anisocytosis measured as a red cell distribution width in patients with colorectal cancer. QJM 2017; 110: 361-7.
  5. Yang D, Quan W, Wu J, et al. The value of red blood cell distribution width in diagnosis of patients with colorectal cancer. Clin Chim Acta 2018; 479: 98-102.
  6. Siegel R, Jemal A. Colorectal cancer facts & Figures, 2011–2013.
  7. Atlanta, GA: American Cancer Society 2011. Group UCSW. United States cancer statistics: 1999–2014 incidence and mortality web-based report. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute 2017.
  8. Gao Y, Wang J, Zhou Y, Sheng S, Qian SY, Huo X. Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep 2018; 8: 2732. Nikolaou S, Qiu S, Fiorentino F, Rasheed S, Tekkis P, Kontovounisios C. Systematic review of blood diagnostic markers in colorectal cancer. Tech Coloproctol 2018; 22: 481-98.
  9. Li Y, Xing C, Wei M, et al. Combining red blood cell distribution width (RDW-CV) and CEA predict poor prognosis for survival outcomes in colorectal cancer. J Cancer 2019; 10: 1162-70.
  10. Zhao JX, Liu LR, Yang XY, Liu F, Zhang ZG. Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients. Oncotarget 2017; 8: 67918-32.
  11. Karsa LV, Lignini TA, Patnick J, Lambert R, Sauvag